GlucoTrack, Inc.
GCTK
$7.42
-$0.24-3.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 102.62% | 219.26% | 123.73% | 63.41% | 25.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.54% | 59.45% | 46.18% | 280.92% | 129.83% |
| Operating Income | -18.54% | -59.45% | -46.18% | -280.92% | -129.83% |
| Income Before Tax | -133.45% | -318.49% | -128.83% | -281.72% | -127.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -133.45% | -318.49% | -128.83% | -281.72% | -127.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -133.45% | -318.49% | -128.83% | -281.72% | -127.60% |
| EBIT | -18.54% | -59.45% | -46.18% | -280.92% | -129.83% |
| EBITDA | -18.43% | -59.09% | -46.65% | -281.04% | -130.23% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |